Article Information
History
- September 15, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- 1Professor of Internal Medicine, Universidad Abierta Interamericana, Argentina; Academic Coordinator at Eurnekian Public Hospital, Argentina
- 2Director of Postgraduate degree program in Infectious Diseases, Universidad de Buenos Aires, Argentina; Head of Department of Infectious Diseases at Hospital of Infectious Diseases Francisco Javier Muñiz, Buenos Aires, Argentina
- 3Head of Service of Clinical Medicine at Eurnekian Public Hospital, Argentina
- ↵*Corresponding author; email: hymcarvallo{at}hotmail.com
* NOTE: This Protocol and its trial were duly submitted to: http://ClinicalTrials.gov Identifier: NCT04425863 Eurnekian Public Hospital Protocol Record IDEA, Ivermectin, Dexametasone, Enoxaparin and Aspirin as treatment for Covid 19.
Posted September 15, 2020.
Safety and Efficacy of the combined use of ivermectin, dexamethasone, enoxaparin and aspirin against COVID 19
